IL1B and metabolic dysfunction-associated steatotic liver disease: Microbes in the intestine are known to directly or indirectly trigger immune responses and inflammations via cytokines like IL-6, IL-1β and TNF-α, with possible NAFLD-ameliorating effects (34).